Grant: Master's Award: Canada Graduate Scholarships
McMaster University
$17,500.00
Mechanisms of damage and potential treatments for antipsychotic-induced parkinsonism
FY 2011-12
Summary
Antipsychotic drugs are commonly used to treat schizophrenia and other psychotic illnesses. While these drugs are effective therapeutically, they have detrimental side effects as well. One of the more common and debilitating side effects is parkinsonism, which is comprised of a number of movement and muscle control problems reminiscent of those experienced in Parkinson's disease. Our lab has demonstrated that antipsychotic drugs have an unintended effect in which pre-synaptic dopamine-producing neurons are damaged over time. It is likely that this damage is responsible for the parkinsonian symptoms observed in clinical populations. Our lab has further demonstrated that antipsychotic-induced damage to dopaminergic neurons is dependent upon dopamine reuptake into the cells, suggesting that increased dopamine concentrations within the neurons may be responsible. We propose a model whereby antipsychotic drugs damage dopaminergic neurons by increasing dopamine synthesis, thereby increasing cytoplasmic dopamine concentrations. This in turn would lead to oxidative stress, the aggregation of damaging alpha-synuclein and tau proteins, and an inflammatory immune response raised against dopamine-producing neurons. Rats will be treated with antipsychotic drugs and brain slices will be stained for various proteins of interest. This will enable us to determine how various antipsychotics affect the aggregation of proteins in dopaminergic neurons and promote the activation of inflammatory cells. Furthermore, it will allow us to assess the ability of potential treatments to reverse these effects. For example, alpha lipoic acid will be used to reduce oxidative stress, and lithium will be used to reduce inflammation and tau phosphorylation. Through the proposed research, we hope to shed light on the mechanisms underlying antipsychotic-induced parkinsonism and take initial steps towards finding effective treatments.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
253344
Name
Rasmussen Sean
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Mechanisms of damage and potential treatments for antipsychotic-induced parkinsonism
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Alpha-Synuclein; Animal Models; Antipsychotic Drugs; Dopamine; Gsk; Immunohistochemistry; Neuroinflammation; Parkinsonism; Tau; Western Blotting
Abstract
Antipsychotic drugs are commonly used to treat schizophrenia and other psychotic illnesses. While these drugs are effective therapeutically, they have detrimental side effects as well. One of the more common and debilitating side effects is parkinsonism, which is comprised of a number of movement and muscle control problems reminiscent of those experienced in Parkinson's disease. Our lab has demonstrated that antipsychotic drugs have an unintended effect in which pre-synaptic dopamine-producing neurons are damaged over time. It is likely that this damage is responsible for the parkinsonian symptoms observed in clinical populations. Our lab has further demonstrated that antipsychotic-induced damage to dopaminergic neurons is dependent upon dopamine reuptake into the cells, suggesting that increased dopamine concentrations within the neurons may be responsible. We propose a model whereby antipsychotic drugs damage dopaminergic neurons by increasing dopamine synthesis, thereby increasing cytoplasmic dopamine concentrations. This in turn would lead to oxidative stress, the aggregation of damaging alpha-synuclein and tau proteins, and an inflammatory immune response raised against dopamine-producing neurons. Rats will be treated with antipsychotic drugs and brain slices will be stained for various proteins of interest. This will enable us to determine how various antipsychotics affect the aggregation of proteins in dopaminergic neurons and promote the activation of inflammatory cells. Furthermore, it will allow us to assess the ability of potential treatments to reverse these effects. For example, alpha lipoic acid will be used to reduce oxidative stress, and lithium will be used to reduce inflammation and tau phosphorylation. Through the proposed research, we hope to shed light on the mechanisms underlying antipsychotic-induced parkinsonism and take initial steps towards finding effective treatments.
Competitiondate
201202
Approvedterm2
1 yr 0 mth
Pinamesdelim
Rasmussen, Sean
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~